Darolutamide roll-over study

People with cancer are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Are enrolled in any Bayer-sponsored darolutamide feeder study at the time of study closure or primary completion, who are currently receiving darolutamide and are experiencing clinical benefit from the treatment

You may NOT participate in this study if you:

  • Have negative benefit/risk ratio as determined by investigator
  • Meet any criteria for treatment discontinuation of the feeder study that you are coming from
  • Are pregnant or breastfeeding

Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Road Bronx, NY 10461
Phone: (718) 405-8209
Email: mportes@montefiore.org